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Introduction
Bio-pharmaceutical industries face an increasing demand
to accelerate process development and reduce costs. This
challenge requires high throughput tools to replace the
traditional combination of shake flasks and small-scale
stirred tank bioreactors. A conventional and widely used
process development tool is the stirred tank reactor (STR)
ranging from approximately 1L to 10L in working volume.
Physical culture parameters such as pH, temperature and
pO2 can be easily controlled in such systems.
However preparation and operation of these systems
are time and resource consuming. The ambr™ system
from TAP Biosystems has the capabilities for automated
sampling, feed addition, and control for pH, dissolved
oxygen, gassing, agitation, and temperature.
Here, through the evaluation of parameters including
cell growth, viability, metabolite concentration and pro-
duction titer during a fed-batch process using CHO cells
producing a recombinant mAb, we assessed the reproduci-
bility of the ambr™ system for standard conditions com-
pared to 2L stirred tank bioreactors and the effects of
parameter ranging between both culture systems, namely
feed rate and pH ranging.
Material and methods
A CHO cell line expressing a recombinant monoclonal
antibody was used. Cells were carried out for 14 days in
a fed-batch mode in a chemically defined medium and
fed according to process description.
Culture systems: ambr™48 is an automated system
with 48 disposable microbioreactor vessels. Results of
ambr™ 48 workstation (TAP Biosystems) were com-
pared to the results obtained with 2L stirred tank bior-
eactors with Biostat B-DCUII control systems (Sartorius
Stedim).
Commercially available production media and feeds
were used as per manufacturer’s recommendations. pH
(7.0 +/- 0.2 for standard conditions). All fed-batch cul-
tures lasted 14 days.
For the scale down model, parameters were divided in
two groups. 1. The scale dependent factors: culture start
volume, feed volumes that are linearly dependent and
agitation speed and gazing that are theoretically or by
experiences determined. 2. The scale independent fac-
tors: Media, temperature, seeding densities, pH, dis-
solved O2, culture duration.
Product quality of the monoclonal antibody produced
was analyzed as follows: Cell culture fluid samples were
centrifuged and filtered to remove cell debris. The
monoclonal antibody was purified by ÄKTA-express
(GE Healthcare) Protein-A purification. The neutralized
eluate was used for product quality analysis.
Sample analysis: Viable Cell Concentration (VCC) and
cell viability were measured using a ViCell XR cell coun-
ter (Beckman Coulter). Metabolite concentrations were
measured by enzymatic assay using a UV-method (R-
Biopharm) for the ambr™ vessels and by a BioProfile Ana-
lyzer 400 (Nova Biomedical) for stirred tank bioreactors.
For both systems, pH measurement was obtained with a
BioProfile pHOx pH/Gas Analyzer (Nova Biomedical),
Osmolality was obtained using a Omometer (Advanced
Instruments). Production titers were measured throughout
the culture using an Octet QK (ForteBio) and after
14 days with protein A HPLC (Agilent) after purification.* Correspondence: frederic.delouvroy@ucb.com
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Design of experiment: A 3x7-factorial design was
implemented using JMP software (SAS). Parameter ran-
ging included pH (6.9, 7.0, and 7.1) and feed rate addi-
tion (±30%, ±20% and ±10% compared to standard
conditions) see Table 1
Results and discussion
The ambr™ run was performed in parallel to a 2L bior-
eactor run. Both experiments were inoculated with the
same pool of cells, same batches of media and feeds were
used in both systems. Different pH setpoints and feed
rates were assessed to determine the impact on cell growth
(see Table 1), viability and mAb titers. Each condition was
tested in duplicates in the ambr ™ minibioreactors and
singlet in 2L bioreactors. The design of experiment is
described in Table 1. The aim of this experiment was to
test the reproducibility within ambr™ and the comparabil-
ity between the minibioreactors and the 2L.
Cell growth and cell viability were monitored daily
throughout the cultures in 2L (control runs, n = 4). In
the ambr™ system, cell density and viability were mea-
sured every two days to avoid excessive sampling on con-
trol runs (n = 6). Cell viabilities were maintained at
acceptable values (>80%) throughout the cultures in the
established culture conditions.(Figure 1). Cell growth and
viability performances observed in the ambr™ minibior-
eactors and 2L bioreactors were comparable (Figure 1).
Final mAb titer obtained using ambr™ showed slightly
(15%) lower concentration than the 2L bioreactors.
Osmolality profiles showed the same trend in 15mL and
2L bioreactors (between and 300 mOsm/kg at the begin-
ning and 420mOsm/kg at the end of the run). Online pH
Table 1 Design of the experiment
pH set point Feed rate Number of replicates in ambr™ run Number of replicates in 2L bioreactor run
7.0 -30% 2 0
7.0 -20% 2 1
7.0 -10% 2 1
7.0 Control feed rate 6 1
7.0 +10% 2 1
7.0 +20% 2 1
7 +30% 2 0
6.9 Control feed rate 2 1
7.1 Control feed rate 2 1
Figure 1 Viable cell concentration (VCC) and viability average comparison between ambr ™ and 2L bioreactors (control runs)
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profiles were also comparable in both ambr™ minibior-
eactors and in 2L bioreactors.
The impact of different feed rates were assessed and
compared between 2L bioreactors stirred tank bioreac-
tors and ambr™ minibioreactors. Obtained results show
similar profiles of viable cell density, cell viability, pre-
harvest Mab titer at day 14 and osmolality profiles with
different feed rates.
High feed rates and low feed rates impact cell growth
profiles and osmolality profiles. The different feed rates
applied do not show any significant impact on the final
mAb titer. Profiles observed in 2L bioreactors and
ambr™ are comparable in both systems, except viability
at the end of the ambr™ run due to a lack of glucose.
The impact of different pH setpoints on cell growth,
viability, final mAb titer and osmolality didn’t showed
significant impact on those parameters in both systems.
mAb titer at day 14 was comparable in 2L stirred bior-
eactors than in the ambr™ system.
Conclusions
Our evaluation of the ambr™ system showed there is
good reproducibility within the 6 ambr™ controls. There
is good comparability in terms of cell growth, product
titer, pH, pO2 and osmolality profiles as well as PQA
obtained between ambr™ and bioreactors despite the
fact ambr™ used a bolus feeding regimen and the stirred
tank bioreactors used a continuous feeding strategy. The
impact of feed rate on cell growth and osmolality upon
feed rate ranging was observed in both culturing systems,
but has no impact on PQA. pH set point ranging did not
have an impact on the measured output parameters in
either scale. ambr™ provides a predictive and resource-
efficient tool to do process development especially media
testing, feeding strategy screening and cell culture pro-
duction conditions.
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